The discovery of suspicious images published in science journals has cast doubt on the results of ground-breaking stem cell research led by a scientist Haruko Obokata.
According to journal Nature, research institute based in Kobe, Riken, that hosted the research, has opened an investigation into whether the photos, which depict the placental development of a mouse, were intentionally altered, the Japan times reported.
The research explored the use of physical stress to induce adult cells in mice to return to an embryonic state.
It appeared to provide a simple solution to the complicated problem of producing stem cells for use in medical treatments.
However, as per journal Nature, some images included in the two papers seem to have been altered, while others bear an unusually strong resemblance to each other.
Meanwhile, Teruhiko Wakayama, a professor at Yamanashi University and a co-author of the papers, told the journal that he was able to reproduce the experiment's results independently and the results are absolutely true.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
